CION Cancer Clinics
Bone marrow transplant for sickle cell: is it right for you? | CION Cancer Clinics
Yes, for some people a bone marrow transplant can end sickle cell disease by replacing the faulty marrow with a donor's healthy marrow. It is usually considered for severe disease, such as stroke or repeated chest crises, and works best with a matched brother or sister. It also carries serious risks, including infections, infertility and death. This guide helps you weigh it with your haematologist. At CION Cancer Clinics, our haematologist cares for anaemia, bleeding, clotting and inherited blood disorders, with ArogyaSri, CGHS and cashless insurance accepted.
On this page
- Can a bone marrow transplant end sickle cell disease?
- Who is usually considered for a transplant?
- How does a transplant compare with ongoing treatment?
- What happens from the first question to recovery?
- What do families often get wrong about transplant?
- What do the transplant words mean?
- What can CION do, and what should you ask?
- Common questions about transplant for sickle cell
The short answer
Can a bone marrow transplant end sickle cell disease?
For some people, yes. A successful bone marrow transplant replaces the marrow that makes sickle-shaped cells with a donor's healthy marrow, and the person can stop living with the disease. It is also a serious treatment with real risks, so it is offered only to carefully chosen patients.
How it works
Your blood cells are made in the soft centre of your bones, the marrow. In sickle cell, that marrow carries the faulty gene. A transplant first uses strong medicines, and sometimes radiation, to clear out the old marrow. Then healthy stem cells from a donor are given through a drip, much like a blood transfusion. Over the following weeks they settle in the bones and start making normal red cells.
Why it is not offered to everyone
The same treatment that can end the disease can also cause life-threatening infections, organ damage, infertility and a reaction in which the donor cells attack the body. For a person whose sickle cell is mild, or well controlled on hydroxyurea, those risks may outweigh the benefit. The decision always weighs how severe the disease is against how safe the transplant is likely to be for that person.
This page is for families weighing a transplant for sickle cell. For how transplants work in blood cancers, see the bone marrow transplant guide linked below.Deciding together
Who is usually considered for a transplant?
A transplant team looks at two things together: how much harm the disease is doing, and whether a safe donor exists.
Severe disease despite treatment
Frequent pain crises or repeated hospital stays even with hydroxyurea and good daily care are one of the commonest reasons to start the conversation.
Stroke or high stroke risk
A child who has had a stroke, or whose brain scans show high risk, may be referred for transplant assessment rather than lifelong transfusions.
Repeated chest crises
More than one episode of acute chest syndrome, the dangerous lung complication, often leads the team to discuss a transplant.
A matched brother or sister
A fully matched sibling who does not have sickle cell disease makes a transplant safer. Siblings with sickle cell trait can often still donate.
Who it usually does not suit
- Mild disease that is well controlled
- Serious heart, lung, liver or kidney damage
- No suitable donor and no access to a trial
Not sure whether this applies to you?
Ask an oncologistSide by side
How does a transplant compare with ongoing treatment?
The pathway
What happens from the first question to recovery?
-
Review by a haematologist
Bring every discharge summary, transfusion record and scan. The haematologist looks at how severe the disease has been and whether a transplant is worth exploring.
-
Tissue typing of the family
The patient and brothers and sisters give a blood or cheek-swab sample for HLA typing at a qualified laboratory. This shows whether anyone is a close match.
-
Fitness checks and counselling
Heart, lung, kidney, liver and brain tests show whether the body can cope. The family hears the risks in detail, and fertility preservation is discussed before treatment starts.
-
Conditioning and the transplant
Strong medicines clear the old marrow. Then the donor cells are given through a drip. The person stays in a protected ward while counts are very low and infection risk is high.
-
Engraftment and going home
When the new marrow starts making cells, counts slowly rise. Going home comes only when the team is satisfied it is safe.
-
The first year and beyond
Frequent clinic visits, blood tests and medicines to protect against infection and donor-cell reactions. Long-term checks continue for years.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
What do families often get wrong about transplant?
It is one of the most demanding treatments in medicine. Recovery takes many months, and some people face long-term effects such as infertility or chronic reactions to the donor cells. Ask about these before, not after.
A fully matched brother or sister is the usual first choice. Some centres also use half-matched family donors, such as a parent, or unrelated donors from a registry. These carry different risks, and not every centre offers them.
Trait carriers are often accepted as donors. The patient then usually lives with trait-like blood, which does not cause sickle cell disease. The transplant team decides donor by donor.
Transplant is often safer in younger people before organ damage builds up. Waiting is sometimes right, but it is a decision to make with a haematologist, not a default.
Words you will hear
What do the transplant words mean?
- HLA match
- How closely the donor's tissue markers match the patient's. A closer match lowers the risk of the body and donor cells reacting against each other.
- Allogeneic transplant
- A transplant using stem cells from another person. This is the kind used in sickle cell.
- Haploidentical
- A half-matched family donor, often a parent. It widens who can donate but has its own risks.
- Conditioning
- The strong medicines, sometimes with radiation, given before the transplant to clear the old marrow.
- Graft-versus-host disease
- When donor immune cells attack the patient's skin, gut or liver. It can be mild or serious.
- Gene therapy
- A newer approach that corrects the patient's own stem cells instead of using a donor. Access in India is still very limited.
Being straight with you
What can CION do, and what should you ask?
CION does not carry out bone marrow transplants. Our haematology team reviews the full history, discusses the case at a tumour board, and helps you reach a qualified transplant centre if a transplant looks worth exploring.
Questions to take to any transplant centre
Ask how many sickle cell transplants the team does, not only blood cancer transplants. Ask which donor types they use, what conditioning they plan, and what their own complication and survival results look like for patients like yours. Ask who looks after you if something goes wrong after you return home to your district.
Paying for it
A transplant is expensive, and the full cost includes typing, the stay, medicines and months of follow-up. Aarogyasri, PM-JAY, CGHS, ECHS, EHS and cashless insurance may cover part of it at empanelled centres. Scheme rules change, so check the current entitlement in writing before admission.
What this page cannot tell you
It cannot tell you whether a transplant is right for your child or for you, or what the outlook would be. That depends on age, organ health, the donor and the centre. Only a haematologist who has seen the whole history can help you weigh it.
Questions we are asked
Common questions about transplant for sickle cell
Is a bone marrow transplant the only way to end sickle cell?
It is the established way at present. Gene therapy, which corrects the patient's own stem cells, has been approved in some countries, but it is very costly and access in India is limited. For most families, the realistic choice is between a transplant and good ongoing care with hydroxyurea and, where needed, transfusions.
How do we find out if a sibling is a match?
The patient and each brother or sister give a small blood or cheek-swab sample for HLA typing at a qualified laboratory. Your haematologist arranges the request and reads the result with you. Parents are usually only half matches, which matters if the centre offers half-matched transplants.
What if there is no matched donor in the family?
Some centres use a half-matched parent or an unrelated donor from a registry. These options carry different and often higher risks, and not every centre offers them for sickle cell. Your haematologist can tell you which centres do, and whether a clinical trial might be open to you.
What are the main risks?
Serious infections while counts are low, damage to organs from the conditioning medicines, graft-versus-host disease, the transplant not taking, and infertility. Death is a real, though uncommon, risk. The transplant centre should explain each risk and what it means for your own situation before you sign consent.
Will my child be able to have children later?
The conditioning medicines often affect fertility. Options to preserve eggs, sperm or tissue exist in some centres, and they need planning before treatment starts. Raise this at the very first transplant meeting, even for a young child, so that nothing is missed.
Should we stop hydroxyurea while we wait for a decision?
No. Keep taking every medicine exactly as prescribed unless your haematologist tells you otherwise. The transplant team will explain any change needed before the transplant itself. Stopping on your own can bring on crises and make the person less fit for a transplant.
Is an adult too old for a transplant?
Not always. Transplants are more often done in children, and risks tend to rise with age and organ damage. Some centres do offer them to adults with severe disease, sometimes with gentler conditioning. The decision depends on overall health, not age alone.
Does Aarogyasri or PM-JAY cover a transplant?
Cover for bone marrow transplant exists under some schemes at empanelled centres, but packages, limits and eligibility vary and change. Ask the transplant centre's scheme desk for the current rules in writing, and check what happens to follow-up costs after discharge.
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- NHS — Sickle cell disease: treatment
- NHLBI — Sickle Cell Disease: Treatment
- American Society of Hematology — Sickle Cell Disease
- National Health Mission, Government of India — National Sickle Cell Anaemia Elimination Mission
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Wondering whether transplant is worth exploring?
Share the discharge summaries and reports. CION's haematology team will review the history and help you reach a qualified transplant centre if it fits.